Current position

Ray Dalio’s Colgate Palmolive Co (CL) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Bridgewater Associates, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2012Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares2.63MHighest verified quarter-end share count
Quarters reported36Verified quarters with shares above zero
What happened?

Bridgewater Associates, LP first reported Colgate Palmolive Co in Q3 2012. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Bridgewater Associates, LP currently reports 77.09K shares. The latest verified filing showed: Sold 8.8% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 8.8% of the position−7.41K shares · 77.09K shares remained
Filing context

Quarter-end price $91.68 · Estimated holding basis $81.06

Q1 2026
Bought 33.9% more+21.40K shares · 84.51K shares reported after the change
Filing context

Quarter-end price $85.23 · Estimated holding basis $81.06

Q4 2025
Sold 47.7% of the position−57.58K shares · 63.10K shares remained
Filing context

Quarter-end price $79.02 · Estimated holding basis $79.65

Q3 2025
Bought 162.6% more+74.73K shares · 120.68K shares reported after the change
Filing context

Quarter-end price $79.94 · Estimated holding basis $79.65

Q2 2025
Sold 24.3% of the position−14.71K shares · 45.95K shares remained
Filing context

Quarter-end price $90.90 · Estimated holding basis $79.18

Q1 2025
Sold 59.6% of the position−89.57K shares · 60.66K shares remained
Filing context

Quarter-end price $93.70 · Estimated holding basis $79.18

Portfolio importance

How important is Colgate Palmolive Co in Bridgewater Associates, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.0%Q2 2026
Current rank#402of 997 reported positions
Peak portfolio weight0.9%Q4 2021
Best historical rank#19Q1 2022
At peak importanceQ4 2021
CL
0.9%
Largest holding
5.2%
Cross-investor discovery

Who else owns Colgate Palmolive Co?

Also reported by 1 other tracked investor in their latest verified filings.

Joel GreenblattGotham Asset Management
CL0.0% of reported portfolio
Explore Colgate Palmolive Co across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$87.002026-09-15

Market context only; not an investor transaction price.

Latest filing quarter-end price$91.68Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$81.06Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Bridgewater Associates, LP’s Form 13F disclosures, not Ray Dalio’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.